Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?
出版年份 2023 全文链接
标题
Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?
作者
关键词
-
出版物
Journal of Cosmetic Dermatology
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-02
DOI
10.1111/jocd.16030
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients
- (2022) Jade Heitz et al. European Journal of Internal Medicine
- Elevated serum level of B‐cell activating factor ( BAFF ) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents
- (2022) Elham Daneshvar et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2022) Sara Thietart et al. JAMA Network Open
- Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study
- (2021) Zeinab Aryanian et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐ to‐treat disease or a consequence of late rituximab initiation?
- (2021) Kamran Balighi et al. Dermatologic Therapy
- Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
- (2020) P. Joly et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2020) Pierre Charles et al. ANNALS OF INTERNAL MEDICINE
- Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era
- (2019) Roosa E. I. Prusila et al. BRITISH JOURNAL OF HAEMATOLOGY
- Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study
- (2018) G. Boleto et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus
- (2018) Julia Sanchez et al. JAMA Dermatology
- Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
- (2018) Liliana Michelle Gomez Mendez et al. Clinical Journal of the American Society of Nephrology
- Rituxan nanoconjugation prolongs drug/cell interaction and enables simultaneous depletion and enhanced Raman detection of lymphoma cells
- (2017) Qian Yao et al. Journal of Materials Chemistry B
- Onset of secondary progressive MS after long-term rituximab therapy - a case report
- (2016) H.-Christian von Büdingen et al. Annals of Clinical and Translational Neurology
- Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis
- (2015) I. Fleury et al. ANNALS OF ONCOLOGY
- Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
- (2015) Emilio Besada et al. PeerJ
- Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
- (2014) W. F. Pendergraft et al. Clinical Journal of the American Society of Nephrology
- Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
- (2013) D. O. Bunch et al. Clinical Journal of the American Society of Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now